Seeking Prostate Cancer Survivors for Technology Discussion



Thanks to Lesly Maranan, for passing this along!

From the desk of Dan Ollendorf, MPH, ARM, Chief Review Officer, Institute for Clinical & Economic Review

I am writing concerning the efforts of a new initiative known as the Institute for Clinical & Economic Review (ICER), a new initiative of Harvard Medical School, that seeks to provide an impartial review of new or emerging healthcare technologies that involves ALL relevant stakeholders (including patients). We are currently evaluating permanent brachytherapy and proton beam therapy for prostate cancer, and would like to include patients who have undergone each of these treatments in our discussion.

While our reviews operate on an 8-month cycle, the time commitment we would need includes an initial, one-hour conference call, review of documents produced during the review cycle at your discretion, and attendance at all or part (again, at your discretion) of a live one-day meeting in the Boston area. You will be compensated for your time.

Our website is under construction, but more information on ICER and its efforts can be found at the Institute for Clinical & Economic Review, click on the ICER button.

Additional note: The menu at the site has a staff icon and from there you can email Dan Ollendorf, directly.

About ICER

“Launched in 200, ICER is an academic technology assessment initiative based at Harvard Medical School. ICER produces rigorous assessments of new medical interventions and translates its findings into integrated ratings specifically formatted to support value-based insurance benefit designs, coverage and reimbursement policy, and patient-clinician decision support tools.”

Related Posts with Thumbnails
Print Friendly

Comments

  1. Thanks, Tina. I’ve got three brothers so I’ll make sure they’re aware of this.

  2. Gina,

    Thank you for dropping by. I have added your name to the book drawing.

  3. Mary, I am so sorry to hear that.

    I checked and found this on the Sloan-Kettering web site.

    Here is what they have posted and a link:
    ” Can susceptibility to prostate cancer be inherited?
    Recent studies have concluded that a susceptibility to prostate cancer can be inherited. It estimated that between 5 to 10 percent of all prostate cancer cases are considered hereditary. This means that in some families, a genetic predisposition to develop prostate cancer can be passed down from parent to child.”
    www.mskcc.org/mskcc/html/8625.cfm

    I will be sure to do a feature on this soon. In the meantime Lesly did one which is linked in the article.

    BTW you are in the book drawing for tomorrow. Thanks for stopping by

  4. Fascinating! I’m looking forward to hearing more.

    Thanks for sharing the information.

  5. My father died after an about ten year battle with prostate cancer so I’m really interested in these studies.
    Does prostate cancer run in families?

Speak Your Mind

*


*

NOTE: The contents in this blog are for informational purposes only, and should not be construed as medical advice, diagnosis, treatment or a substitute for professional care. Always seek the advice of your physician or other qualified health professional before making changes to any existing treatment or program. Some of the information presented in this blog may already be out of date.
Read previous post:
Arthritis in Canadian Aboriginal Population

Among aboriginal people of Canada, severe forms of arthritis are five times more common than the rest of the Canadian...

Close